Chemoinformaics analysis of (2R,5S,8S)-2,5,6,8-TETRAMETHYLTRICYCLO[6.3.0.01,5]UNDEC-6-ENE
| Molecular Weight | 204.357 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 204.188 | nRing | 3 |
| Solubility: LogS | -4.662 | nHRing | 0 |
| Solubility: LogP | 4.34 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.507 |
| Synth | 5.17 |
| Natural Product Likeliness | 2.807 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.566 |
| MDCK | 0.0000131 |
| BBB | 0.16 |
| PPB | 0.947711 |
| VDSS | 2.234 |
| FU | 0.0543265 |
| CYP1A2-inh | 0.171 |
| CYP1A2-sub | 0.882 |
| CYP2c19-inh | 0.421 |
| CYP2c19-sub | 0.952 |
| CYP2c9-inh | 0.221 |
| CYP2c9-sub | 0.415 |
| CYP2d6-inh | 0.085 |
| CYP2d6-sub | 0.437 |
| CYP3a4-inh | 0.643 |
| CYP3a4-sub | 0.743 |
| CL | 13.74 |
| T12 | 0.086 |
| hERG | 0.024 |
| Ames | 0.031 |
| ROA | 0.1 |
| SkinSen | 0.422 |
| Carcinogencity | 0.291 |
| EI | 0.894 |
| Respiratory | 0.903 |
| NR-Aromatase | 0.71 |
| Antiviral | Yes |
| Prediction | 0.916098 |